Status | Study |
Completed |
Study Name: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) Condition: Visceral Leishmaniasis Human African Trypanosomiasis Enter Date: 2013-01-09 Interventions: Device: rk28 ICT rk28 ICT is a |
Completed |
Study Name: Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever Condition: Familial Mediterranean Fever, Date: 2012-09-27 Interventions: Drug: Kineret Patients randomized to active drug will receive Kineret(Anakinra), 100 mg prefilled syring |
Not yet recruiting |
Study Name: Progression of Renal Amyloidosis of FMF and Relation to Serum SAA Level Condition: Observational Date: 2010-07-22 |
Completed |
Study Name: Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF) Condition: Colchicine Resistant/Intolerant Familial Mediterranean Fever Date: 2010-06-21 Interventions: Drug: Canakinumab |
Completed |
Study Name: Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever Condition: Familial Mediterranean Fever Date: 2010-03-16 Interventions: Drug: Canakinumab |
Completed |
Study Name: Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients Condition: Familial Mediterranean Fever Date: 2010-02-24 Interventions: Drug: colchicine sprinkle capsules 0.3 mg |
Completed |
Study Name: Heat Intolerance in the Group of FMF Patients Condition: Familial Mediterranean Fever Heat Intolerance Date: 2010-01-28 |
Completed |
Study Name: Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing Condition: Cardiac Function Date: 2009-11-30 Interventions: Drug: regadenoson Regadenoson dose of 400 mcg will be infused over 10-20 seconds followed by a saline fl |
Completed |
Study Name: Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients Condition: Familial Mediterranean Fever Date: 2008-04-08 |
Completed |
Study Name: Rilonacept for Treatment of Familial Mediterranean Fever (FMF) Condition: Familial Mediterranean Fever Date: 2007-12-19 Interventions: Drug: Rilonacept 2.2 mg/kg/wk |